Abstract:The aims of this study were to apply integrative cardiopulmonary ultrasound (thoracic ultrasound) to the evaluation of patients with interstitial lung disease (ILD) and to determine the relationship between lung ultrasound signs and echocardiographic parameters such as systolic pulmonary artery pressure (SPAP) and various right ventricular parameters. ILD patients and healthy controls underwent lung ultrasound (LUS) and echocardiographic tests. In addition to traditional echocardiographic parameters, right ventricular free wall longitudinal strain (RVLS_FW) was measured using 2-D speckle-tracking echocardiography. The degree of pulmonary fibrosis or the disease severity of each ILD patient was scored with a semiquantitative scoring method, taking into account multiple LUS signs. Statistical analyses were performed to compare various parameters between ILD patients with and those without pulmonary hypertension. Correlations between the different parameters were then evaluated, and the LUS scores were used to predict pulmonary hypertension using a receiver operating characteristic curve analysis. Among the 90 patients who qualified for entry into this study, 30% (n = 27) had pulmonary hypertension. The patients with pulmonary hypertension had larger right ventricular dimensions, lower RVLS_FW and higher LUS scores. An effective correlation was found between ILD LUS scores and echocardiographic parameters, especially SPAP (r = 0.735, p < 0.001). The groups were comparable with respect to most echocardiographic parameters, with mild, moderate and severe pulmonary fibrosis, whereas SPAP was significantly higher in the moderate and severe groups. RVLS_FW was obviously reduced in the group with severe pulmonary fibrosis. Although RVLS_FW in the mild pulmonary fibrosis group was in the normal range, it was slightly reduced compared with that of the controls. A cutoff of more than 16 LUS points had 85.2% sensitivity and 80.3% specificity in predicting elevated SPAP (>36 mm Hg). Thoracic ultrasound is useful in the assessment of ILD. As ILD progresses, the structure or function of the right ventricle gradually deteriorates. LUS not only detects lung conditions in ILD, but also indirectly reflects SPAP and right ventricular function. Integrated use of LUS and echocardiography will provide an invaluable point-of-care imaging modality to facilitate the diagnosis, management and treatment of patients with ILD.

Noninvasive diagnostic modalities and prediction models for detecting pulmonary hypertension associated with interstitial lung disease: a narrative review

Pulmonary Hypertension in Interstitial Lung Disease: A Systematic Review and Meta-Analysis

Non-invasive Screening for Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis.

P158 Pulmonary Vascular Disease Markers Predict Death in Interstitial Lung Disease Patients Proven Not to Have Pulmonary Hypertension at Right Heart Catheter

Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need

Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future

S55 Derivation and Validation of a Simple Longitudinal Score Which Strongly Predicts Mortality in Interstitial Lung Disease (ild) Associated Pulmonary Hypertension (Ild-Ph)

A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease

Assessing the precision of machine learning for diagnosing pulmonary arterial hypertension: a systematic review and meta-analysis of diagnostic accuracy studies

Diagnostic test accuracy of artificial intelligence analysis of cross-sectional imaging in pulmonary hypertension: a systematic literature review

Machine Learning for Diagnosis of Pulmonary Hypertension by Echocardiography

Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility

Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis

Publishing Trends in World Journal of Pediatric Surgery

Improving Prognostication in Pulmonary Hypertension Using AI-quantified Fibrosis and Radiologic Severity Scoring at Baseline CT

Artificial intelligence meets pulmonary hypertension: early detection for a late-presenting disease

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension

Integrative Cardiopulmonary Ultrasound for Interstitial Lung Disease Assessment: Correlation Between Lung Ultrasound Performance and Cardiac Involvement.

Risk prediction in pulmonary hypertension due to chronic heart failure: incremental prognostic value of pulmonary hemodynamics

Echocardiographic artificial intelligence for pulmonary hypertension classification

Pulmonary hypertension associated with lung diseases